Berkley W R Corp Boosts Stock Holdings in Aimei Health Technology Co., Ltd. $AFJK

by · The Cerbat Gem

Berkley W R Corp boosted its stake in Aimei Health Technology Co., Ltd. (NASDAQ:AFJK – Free Report) by 5.9% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 450,655 shares of the company’s stock after purchasing an additional 25,294 shares during the quarter. Berkley W R Corp owned about 7.36% of Aimei Health Technology worth $5,101,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Wellspring Financial Advisors LLC purchased a new position in shares of Aimei Health Technology during the second quarter valued at about $133,000. Clear Street LLC lifted its position in shares of Aimei Health Technology by 63.8% in the second quarter. Clear Street LLC now owns 39,525 shares of the company’s stock worth $441,000 after buying an additional 15,399 shares in the last quarter. Finally, Crossingbridge Advisors LLC bought a new position in Aimei Health Technology during the second quarter valued at approximately $2,147,000. Institutional investors own 45.58% of the company’s stock.

Wall Street Analysts Forecast Growth

AFJK has been the subject of several research analyst reports. Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a report on Monday, December 29th. Wall Street Zen raised Aimei Health Technology to a “sell” rating in a report on Saturday, January 17th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

Check Out Our Latest Analysis on AFJK

Aimei Health Technology Trading Down 4.3%

AFJK stock opened at $25.61 on Friday. The stock has a market cap of $156.73 million, a PE ratio of 121.96 and a beta of -2.95. Aimei Health Technology Co., Ltd. has a 12 month low of $6.75 and a 12 month high of $130.37. The company has a 50-day moving average price of $46.88 and a 200 day moving average price of $28.62.

About Aimei Health Technology

(Free Report)

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.

Further Reading